For most of its life, semaglutide for weight management has meant an injection: one pen, once a week, on a chosen day, with the storage and travel planning that pens invite. It now also means a tablet, swallowed every morning, under the same Wegovy name. The molecule is the same. The approved purposes overlap at the top level. The daily experience is genuinely different, with a different ladder, different rules and one indication that did not come along.
This page is about the tablet. What changes when the pen becomes a pill, what the label asks of a morning, what the tablet is approved for, and what a daily cadence does to the habit of tracking. Whether tablet or injection suits any particular person is a prescriber conversation, shaped by history, coverage and preference, and nothing here argues either side of it.
A trade, not an upgrade
The tablet's offer is straightforward. No needles, no injection anxiety, no pen to store or shepherd through a trip. What it asks in return is attention every single day rather than once a week. A weekly injection compresses the routine into one remembered event, a day you pick and a ritual you build around it. A daily tablet spreads the same treatment across 365 mornings, and each morning carries rules that the label sets out precisely.
Neither cadence is better in the abstract, and this article will not pretend otherwise. The honest comparison is about what kind of routine fits a life: one weekly event worth marking, or one daily action small enough to disappear into the start of the day. The pharmacology behind why some of these medicines are weekly and others daily is covered in Why Some GLP-1s Are Weekly and Others Daily, and it is the reason the tablet asks for a completely different kind of consistency.
The ladder: four steps of 30 days
Per the prescribing information, the tablet ladder looks like this:
| Days | Daily dose |
|---|---|
| Days 1 through 30 | 1.5 mg once daily |
| Days 31 through 60 | 4 mg once daily |
| Days 61 through 90 | 9 mg once daily |
| Day 91 onward | 25 mg once daily, the recommended maintenance dosage |
Two pieces of escalation language in the label deserve plain reporting. If a dose is not tolerated during the climb, the label says to consider delaying the escalation. And if the 25 mg maintenance dosage is not tolerated, the label says to consider switching to Wegovy injection at 1.7 mg once weekly. That second instruction is unusual enough to deserve its own sentence: the same label that starts a person on tablets offers a printed route back to the pen. Every one of these steps, holds and switches belongs to the prescriber.
Next to the injection's ladder, the shape is different in both directions. Each tablet step runs 30 days, slightly longer than the injection's four week steps, but there are four of them rather than five, and maintenance arrives at day 91. The injection's schedule, five steps reaching its maintenance dose in week seventeen, is tabulated in Wegovy Dose Schedule: The Five-Step Titration, Tracked. The numbers are also a reminder that these are different products on different ladders, and the milligrams on one ladder mean nothing when read against the other.
The morning rules
How the tablet is taken will be familiar to anyone who knows oral semaglutide at diabetes doses, because it is the same discipline. Once daily in the morning, on an empty stomach, with plain water only, up to 4 ounces, which is 120 mL. Swallow the tablet whole; do not split, crush, chew or dissolve it. Then wait at least 30 minutes before eating food, drinking anything other than that water, or taking other oral medications.
That 30 minute window is where adherence actually breaks. It collides with breakfast, with coffee, and above all with other morning medications, which many people taking these medicines also have. The subject of timing GLP-1s against the rest of the pillbox has its own page in GLP-1s and Your Other Pills: What the Labels Say About Timing, and it deserves a look before the first tablet rather than after a missed window. Nobody should rearrange another medicine's schedule on an article's say so; that is a conversation with a prescriber or pharmacist.
What to do about a missed tablet is deliberately not covered here, because the answer belongs to the prescribing information and the prescriber rather than to improvisation. The general principles for missed GLP-1 doses across the class are collected in Missed Your GLP-1 Dose? What the Official Guidance Says, and the universal rule holds everywhere in this class: never take a double dose to catch up.
GLP 1 Tracker AppDaily dose logging with the tablet ladder built in, reminders, and side effect notes for the week after each step. Made for a habit that repeats every morning.
Get the app
What the tablet is approved for
Wegovy tablets are indicated, with a reduced calorie diet and increased physical activity, for two uses. The first is reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight. The second is reducing excess body weight and maintaining that reduction long term, in adults with obesity, or adults with overweight plus at least one weight related comorbid condition.
What did not come along from the injection label matters just as much. The MASH liver indication belongs to Wegovy injection only; the tablet carries no liver indication. The pediatric weight indication for patients aged 12 and older also belongs to the injection only. Two forms, one brand name, different approved uses, which is a good demonstration of the fact that indications attach to products rather than to brand names or molecules.
The shared label also carries a limitation of use worth quoting in plain terms: using Wegovy tablets or Wegovy injection together with other semaglutide containing products, or with any other GLP-1 receptor agonist, is not recommended. And the tablet sits in a wider family it must not be confused with. Oral semaglutide at diabetes doses ships under two brand names on one shared label, Rybelsus and Ozempic tablets, indicated for blood sugar control and cardiovascular risk reduction in adults with type 2 diabetes, and that label states the two are not substitutable on a mg to mg basis. Those are different products at different strengths from Wegovy tablets, and none of them can be swapped for another. The diabetes side of oral semaglutide has its own guide in Tracking Rybelsus: Daily Oral Semaglutide and Its Rules.
A daily habit is a different thing to track
The tracking implications of the tablet are not cosmetic. On a weekly medicine, the dose log is a series of events: shot day, site, note, next week. On a daily tablet, the log is closer to a streak, and the thing worth seeing is not the last dose but the shape of the last month: which mornings held, which slipped, where the 30 minute window was tight against breakfast or another pill. A reminder matters more when the cadence is daily, because there is no weekly ritual to lean on and the memory has 364 other days to blend into.
That is the honest product angle. An app that logs the daily ladder, nudges the morning and holds side effect notes beside the dose history is doing the same job for the tablet that a shot tracker does for the pen: replacing memory with record. The habit changes shape between the two forms, but the underlying discipline, writing down what actually happened so the next appointment has facts to work with, is identical.
Frequently asked questions
How do you take Wegovy tablets?
Once daily in the morning, on an empty stomach, with plain water only, up to 4 ounces, which is 120 mL. The tablet is swallowed whole and must not be split, crushed, chewed or dissolved. After taking it, wait at least 30 minutes before eating food, drinking anything other than the water, or taking other oral medications.
What is the Wegovy tablet dose schedule?
Per the prescribing information, the ladder runs 1.5 mg once daily for days 1 through 30, then 4 mg for days 31 through 60, then 9 mg for days 61 through 90, then 25 mg from day 91 onward, which is the recommended maintenance dosage. If a dose is not tolerated during the climb, the label says to consider delaying the escalation. Every step belongs to the prescriber.
What happens if the 25 mg maintenance dose is not tolerated?
The label addresses this directly: if the 25 mg maintenance dosage is not tolerated, consider switching to Wegovy injection at 1.7 mg once weekly. It is an unusual instruction, a printed route from the pill back to the pen on the same label. Whether any switch happens, and when, is a prescriber decision, never a do it yourself move.
Are Wegovy tablets the same as Rybelsus?
No. They are different products at different strengths. Oral semaglutide at diabetes doses ships under two brand names on one shared label, Rybelsus and Ozempic tablets, indicated for blood sugar control and cardiovascular risk reduction in adults with type 2 diabetes, and that label states the two are not substitutable on a mg to mg basis. Wegovy tablets are the weight management product. None of these can be swapped for another.
Are Wegovy tablets approved for the same uses as the injection?
Not quite. The tablets carry the two core indications: cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight, and long term weight reduction in adults with obesity or overweight plus a weight related condition. The MASH liver indication and the pediatric weight indication for patients 12 and older belong to the injection only. The label also does not recommend combining either form with other semaglutide products or any other GLP-1 receptor agonist.